A genome-wide Association study of the Count of Codeine prescriptions

Abstract Opioid prescription records in existing electronic health record (EHR) databases are a potentially useful, high-fidelity data source for opioid use-related risk phenotyping in genetic analyses. Prescriptions for codeine derived from EHR records were used as targeting traits by screening 16 ...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Wenyu Song, Max Lam, Ruize Liu, Aurélien Simona, Scott G. Weiner, Richard D. Urman, Kenneth J. Mukamal, Adam Wright, David W. Bates
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Nature Portfolio 2024-10-01
Loạt:Scientific Reports
Những chủ đề:
Truy cập trực tuyến:https://doi.org/10.1038/s41598-024-73925-4
Miêu tả
Tóm tắt:Abstract Opioid prescription records in existing electronic health record (EHR) databases are a potentially useful, high-fidelity data source for opioid use-related risk phenotyping in genetic analyses. Prescriptions for codeine derived from EHR records were used as targeting traits by screening 16 million patient-level medication records. Genome-wide association analyses were then conducted to identify genomic loci and candidate genes associated with different count patterns of codeine prescriptions. Both low- and high-prescription counts were captured by developing 8 types of phenotypes with selected ranges of prescription numbers to reflect potentially different levels of opioid risk severity. We identified one significant locus associated with low-count codeine prescriptions (1, 2 or 3 prescriptions), while up to 7 loci were identified for higher counts (≥ 4, ≥ 5, ≥6, or ≥ 7 prescriptions), with a strong overlap across different thresholds. We identified 9 significant genomic loci with all-count phenotype. Further, using the polygenic risk approach, we identified a significant correlation (Tau = 0.67, p = 0.01) between an externally derived polygenic risk score for opioid use disorder and numbers of codeine prescriptions. As a proof-of-concept study, our research provides a novel and generalizable phenotyping pipeline for the genomic study of opioid-related risk traits.
số ISSN:2045-2322